www.baxdela.com

This site is intended for US Healthcare Professionals. If you are a US Healthcare Professional, click OK to continue.

OK
CANCEL

Baxdela is your Path Forward.

Pathway to Efficacy

Broad Coverage for ABSSSI: gram-positive pathogens, including MRSA, and gram-negative pathogens, including Pseudomonas aeruginosa. See full Indication

See Baxdela ABSSSI Efficacy Results

Explore Safety
& Tolerability

See Baxdela ABSSSI Safety Profile

Dosing & Administration

See BAXDELA Dosing & Administration

Next: Introduction

Melinta Therapeutics, Inc. - The Antibiotics Company

Medical Information
For medical inquiries or to report an adverse event, other safety-related information, or product complaints for a company product, please contact Medical Information. Phone: 1-844-MED-MLNT (1-844-633-6568)
medinfo@melinta.com
www.melintamedicalinformation.com

©2019 All rights reserved. PP-BAX-US-0399 Terms of Use

BAXDELA® is indicated in adults for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) caused by designated susceptible bacteria.